Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Ahmann

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Reduction of hospital costs and length of stay by good control of blood glucose levelsAndrew Ahmann
The American Journal of Managed Care|April 27, 2011
Application of comparative effectiveness research in evaluation of treatments for type 2 diabetes mellitusAndrew Ahmann
Drugs in Context|December 4, 2015
Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulinAndrew Ahmann
Diabetes Technology & Therapeutics|June 7, 2017
Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome StudiesJanet B McGill, Andrew Ahmann
Diabetes Technology & Therapeutics|February 3, 2021
Type 2 Diabetes and the Use of Real-Time Continuous Glucose MonitoringMelanie A Jackson, Andrew Ahmann, Viral N Shah
Journal of the American Pharmacists Association : Japha|September 11, 2022
Implementation of a pharmacist-led diabetes management service in an endocrinology clinicRita Parsiani, Rachael Lundy, Andrew Ahmann, et al.
Diabetes Technology & Therapeutics|November 26, 2013
Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetesAndrew Ahmann, Sheryl L Szeinbach, Jasvinder Gill, et al.
The American Journal of Clinical Nutrition|August 24, 2004
Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetesGlenn T Gerhard, Andrew Ahmann, Kaatje Meeuws, et al.
Diabetes Technology & Therapeutics|April 25, 2014
Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensorTimothy S Bailey, Andrew Ahmann, Ronald Brazg, et al.
NEJM Evidence|June 23, 2025
Semaglutide in Adults with Type 1 Diabetes and ObesityViral N Shah, Halis K Akturk, Davida Kruger, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Reduction of hospital costs and length of stay by good control of blood glucose levelsAndrew Ahmann
The American Journal of Managed Care|April 27, 2011
Application of comparative effectiveness research in evaluation of treatments for type 2 diabetes mellitusAndrew Ahmann
Drugs in Context|December 4, 2015
Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulinAndrew Ahmann
Diabetes Technology & Therapeutics|June 7, 2017
Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome StudiesJanet B McGill, Andrew Ahmann
Diabetes Technology & Therapeutics|February 3, 2021
Type 2 Diabetes and the Use of Real-Time Continuous Glucose MonitoringMelanie A Jackson, Andrew Ahmann, Viral N Shah
Journal of the American Pharmacists Association : Japha|September 11, 2022
Implementation of a pharmacist-led diabetes management service in an endocrinology clinicRita Parsiani, Rachael Lundy, Andrew Ahmann, et al.
Diabetes Technology & Therapeutics|November 26, 2013
Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetesAndrew Ahmann, Sheryl L Szeinbach, Jasvinder Gill, et al.
The American Journal of Clinical Nutrition|August 24, 2004
Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetesGlenn T Gerhard, Andrew Ahmann, Kaatje Meeuws, et al.
Diabetes Technology & Therapeutics|April 25, 2014
Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensorTimothy S Bailey, Andrew Ahmann, Ronald Brazg, et al.
NEJM Evidence|June 23, 2025
Semaglutide in Adults with Type 1 Diabetes and ObesityViral N Shah, Halis K Akturk, Davida Kruger, et al.
Pageof 3